Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed (HIPEC)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01617382 |
Recruitment Status
:
Recruiting
First Posted
: June 12, 2012
Last Update Posted
: July 29, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Peritoneal Carcinomatosis Pseudomyxoma Peritonei Peritoneal Mesothelioma |
To register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC. In this surgical intervention, the abdominal cavity is macroscopically cleared of tumor, by removing all visible tumor nodules, and is subsequently rinsed with hyperthermic (heated) chemotherapy, aiming to destroy all residual invisible tumor cells that might have stayed behind after the debulking.
The eventual aim of this procedure is to improve the prognosis/survival of patients with malignancies localized on the peritoneal surface.
Study Type : | Observational |
Estimated Enrollment : | 125 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Register With Data From Patients With the Diagnosis of a Peritoneal Surface Malignancy, for Which Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) is Performed |
Study Start Date : | May 2012 |
Estimated Primary Completion Date : | June 2018 |
Estimated Study Completion Date : | June 2019 |

Group/Cohort |
---|
Registry
Patients with peritoneal carcinomatosis of colorectal origin, patients with pseudomyxoma peritonei (type DPAM or PMCA) and patients with peritoneal mesothelioma who are planned to undergo cytoreductive surgery and HIPEC because of a peritoneal surface malignancy
|
- To improve the prognosis/survival of patients with malignancies localized on the peritoneal surface. [ Time Frame: Follow-up over a time period of at least 5 years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients with peritoneal carcinomatosis of colorectal origin, patients with pseudomyxoma peritonei (type DPAM or PMCA) and patients with peritoneal mesothelioma who are planned to undergo cytoreductive surgery and HIPEC because of a peritoneal surface malignancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01617382
Contact: Isabelle B Terrasson | +32 16 340837 | isabelle.terrasson@uzleuven.be |
Belgium | |
University Clinics Gasthuisberg | Recruiting |
Leuven, Flemish Brabant, Belgium, 3000 | |
Contact: Isabelle B Terrasson +32 16 340837 isabelle.terrasson@uzleuven.be | |
Contact: Daphne Hompes, MD +32 16 341826 daphne.hompes@uzleuven.be | |
Principal Investigator: André JL D'HOORE, PhD |
Principal Investigator: | André JL D'Hoore, PhD | University Clinics Gasthuisberg Department of Abdominal Surgery |
Responsible Party: | Universitaire Ziekenhuizen Leuven |
ClinicalTrials.gov Identifier: | NCT01617382 History of Changes |
Other Study ID Numbers: |
S-54350 |
First Posted: | June 12, 2012 Key Record Dates |
Last Update Posted: | July 29, 2016 |
Last Verified: | July 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Keywords provided by Universitaire Ziekenhuizen Leuven:
HIPEC Hyperthermic (heated) chemotherapy after debulking |
Additional relevant MeSH terms:
Pseudomyxoma Peritonei Mesothelioma Carcinoma Fever Adenoma Neoplasms, Glandular and Epithelial |
Neoplasms by Histologic Type Neoplasms Neoplasms, Mesothelial Body Temperature Changes Signs and Symptoms Neoplasms, Cystic, Mucinous, and Serous |